by Lexplosion Solution | Feb 19, 2022 | Central, Drugs and medicine, OPS | 0 comments Health Ministry eases norms for manufacture and stocking of new drugs (under Phase III clinical trials) for treating Covid-19 and related diseases You need to be logged in to view this content. Please Log In. Not a Member? Join Us Share this: Share Tweet Pin LinkedIn Related Posts:Health Ministry prohibits the manufacture, sale or…New Drugs and Clinical Trials Rules amended to…Public comments invited till 25th April, 2024 on…DCGI specifies select countries for considering… centralDrugs and MedicinesOperations Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
